Dubai, UAE : Al Khayyat Investment Company ( AKI ), one of the UAE’s leading diversified family groups, has announced a strategic investment of US$ 100 million to launch VetHealth , a new business unit specializing in the veterinary sector, aiming to provide world-class animal health solutions to a wider range of institutions and government entities across the region.

This investment reflects Al Khayyat Investments' conviction that animal health is a cornerstone of regional food security, enhancing the resilience of public health systems and supporting sustainable economic development. Through VetHealth , the company seeks to contribute to national initiatives aimed at promoting development in the region, including the UAE Food Security Strategy 2051.

VetHealth is headquartered in the United Arab Emirates, where it supports the livestock production sector, as well as the rapidly growing pet industry. The company's launch comes at a time when the veterinary healthcare market in the Middle East and Africa is projected to reach US$ 6.91 billion [1] by 2033, driven by increasing demand for enhanced livestock productivity and a significant rise in pet ownership.

Upon launch, VetHealth will operate across five key sectors: veterinary pharmaceuticals, bioproducts, biosecurity, nutrition, and diagnostics. The company will also collaborate closely with leading regional and global players in these fields to accelerate its expansion in regional markets and support long-term business growth.

Building on Al Khayyat Investments’ long-standing legacy of six decades in the healthcare sector, VetHealth will provide an integrated platform that combines global expertise and specialized solutions to serve the animal health sector in the region.

VetHealth is fully prepared to serve a wide range of clients, including livestock farms and feed mills, veterinary clinics and pharmacies, and government agencies working in animal welfare and biosecurity for food-producing animals. By combining Al Khayyat Investment's expertise in health innovation with its extensive regional distribution network, this investment reinforces the group's position as a key player in the region's animal health sector.

Commenting on this move, Zaid Saad Al Khayat, Managing Director of Al Khayat Investment Company , said: “Animal health is a strategic factor supporting food security, public health and long-term economic resilience. Through this investment, we are building a regional platform that connects governments, producers, veterinarians and global partners with reliable solutions and global standards. This project reflects a long-term commitment to strengthening systems that protect animals, humans and communities across the region.”

For his part, Malek Hassan, General Manager of AKI Environmental - VetHealth, said : “ At Al Khayyat Investment Company, we are keen to invest in sectors that create real and sustainable value for society. VetHealth embodies our belief in the importance of responsible and compassionate care. We are committed to supporting specialists, institutions and various stakeholders in the sector, in a way that contributes to promoting animal health and ensuring the sustainability of food production in the region.”

About Al Khayyat Investment Company

Dr. Saad Al Khayyat founded Al Khayyat Investment Company in 1982 in Dubai, a leading Emirati family business operating in several industries across the Middle East. These industries include pharmaceuticals, medical equipment, retail, consumer goods (food and non-food), fitness, automotive, environmental services, logistics, manufacturing, and contracting. The group currently employs approximately 11,000 people across the UAE and its branches in other GCC countries, Iraq, Jordan, and Egypt. The company was ranked among the top 100 Arab family businesses in 2026 by Forbes Middle East.

-I finish-

#Company Data

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.